SPHERE Per-AF Post-Approval Study
Public ClinicalTrials.gov record NCT06858306. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
SPHERE Per-AF Post-Approval Study, an Addendum to the Affera Global Registry
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
SPHERE Per-AF Post-Approval Study is a prospective, multi-center, non-randomized, observational trial. Subjects will be treated with the Sphere-9™ Catheter and Affera™ Ablation System and followed through 36 months.
Study identification
- NCT ID
- NCT06858306
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 24, 2025
- Primary completion
- Sep 30, 2030
- Completion
- Sep 30, 2030
- Last update posted
- Jun 17, 2026
2025 – 2030
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Hospital | Birmingham | Alabama | 35294 | — |
| Sarasota Memorial Hospital | Sarasota | Florida | 34239 | — |
| Piedmont Heart Institute | Atlanta | Georgia | 30309 | — |
| Minneapolis Heart Institute Foundation | Minneapolis | Minnesota | 55407 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Montefiore Medical Center | New York | New York | 10467 | — |
| Atrium Health Carolinas Medical Center | Charlotte | North Carolina | 28230 | — |
| OhioHealth | Columbus | Ohio | 43214 | — |
| Doylestown Health Cardiology | Doylestown | Pennsylvania | 18901 | — |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | — |
| Texas Health Resources | Fort Worth | Texas | 76104 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| University of Virginia Medical Center | Charlottesville | Virginia | 22903 | — |
| Centra Medical Group Stroobants Cardiovascular Center | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06858306, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06858306 live on ClinicalTrials.gov.